Clinical Trials Logo

Anesthesia clinical trials

View clinical trials related to Anesthesia.

Filter by:

NCT ID: NCT03347409 Completed - Surgery Clinical Trials

Validation of an ERAS Protocol in Gynecological Surgery

ERASGYNBS001
Start date: June 14, 2017
Phase: N/A
Study type: Interventional

Validation of ERAS interventional measures in elective gynecological surgery, for benign either malignant pathology.

NCT ID: NCT03346031 Completed - Anesthesia Clinical Trials

The Effect of Music Therapy on Analgesia and Oxidative Stress Parameters

Start date: October 15, 2017
Phase: N/A
Study type: Interventional

Music has been used in the treatment of patient since the time Plato, Hippocrates and Alpharabius were alive. It is used by music therapists to help patients' social, physical, emotional, psychological and spiritual needs. In a study conducted, it was seen that music has a positive effect on pain, anxiety, depression, shortness of breath, mood, face expression and speech. Our aim is to evaluate the analgesic consumption of music therapy during egg collection applications and to compare the parameters of oxidative stress in blood and follicular fluid.

NCT ID: NCT03344445 Active, not recruiting - Anesthesia Clinical Trials

Difference of Information Gain Between Video-base and Doctor Interview After Preanesthetic Visit

Start date: January 1, 2017
Phase: N/A
Study type: Interventional

To investigate the differenec of patients' satisfaction and information gain betweem face-to-face interview and video introduction

NCT ID: NCT03343496 Completed - Anesthesia Clinical Trials

Simplification and Implementation of Awake Fibreoptic Orotracheal Intubation

Start date: November 17, 2017
Phase:
Study type: Observational [Patient Registry]

Awake fibreoptic intubation (AFOI) is a classic and standard method for some special patients which is also difficult for anesthesiologists to learn and master. The procedure is sometimes hard and often takes about 20-30 min. Most of patients have a strong sense of discomfort. Investigators conducted the research to study the simplification and feasibility of AFOI.

NCT ID: NCT03336801 Completed - Anesthesia Clinical Trials

The Effect of Propofol or Sevoflurane on Renal Function

Start date: September 1, 2017
Phase: Phase 4
Study type: Interventional

This study investigates the role of the anesthetic agents propofol and sevoflurane on renal function in otherwise healthy patients undergoing basic back surgery.

NCT ID: NCT03335579 Completed - Anesthesia Clinical Trials

General Anesthetic Mode and Postoperative Complications

Start date: December 31, 2016
Phase: N/A
Study type: Observational

The relationship between anesthetic medication and postoperative major cardiac and cerebral complications will be studied using logistic regression model.

NCT ID: NCT03329456 Completed - Anesthesia Clinical Trials

MEV to Block the Posterior and Lateral Cords of the Infraclavicular Brachial Plexus

LSIB
Start date: October 30, 2017
Phase: Phase 4
Study type: Interventional

The investigators have recently shown that LSIB in combination with a suprascapular and a cervical plexus block is a very good alternative for arthroscopic shoulder surgery. However, the investigators believe the total volume of local anesthetic for LSIB may be reduced. For shoulder surgery there is no need to block the medial cord and the investigators therefore hypothesize a significantly lower MEV95% by applying a selective lateral and posterior cord block

NCT ID: NCT03324490 Completed - Anesthesia Clinical Trials

Thoracic Spinal Versus Epidural Anesthesia for Nephrectomy in Obstructive/Restrictive Lung Disease Patients

Start date: November 1, 2017
Phase: N/A
Study type: Interventional

Patients with respiratory disease have an increased risk of developing complications perioperatively. The use of regional anesthesia decreases this risk with better postoperative outcome. The aim of this study is to compare the safety and efficacy of thoracic spinal versus thoracic epidural anesthesia for open nephrectomy in patients with obstructive/restrictive lung disease.

NCT ID: NCT03324269 Completed - Pain Clinical Trials

Evaluating the Predictive Value of the Nociception Level Index NOL

Start date: October 1, 2017
Phase: N/A
Study type: Interventional

Opioids remain the cornerstone for perioperative analgesia, albeit frequently associated with side effects. Most of these side-effects are dose-dependent. Thus intra-operative monitors are necessary to measure the balance between Nociception and Anti-Nociception (NAN balance) by an adequate opioid administration. Recently the NOL monitor was released.The NoL index ranges from 0 to 100 and is based on a nonlinear combination of nociception-related physiologic variables, specifically heart rate (HR), heart rate variability at the 0.15- to 0.4-Hz band power, photoplethysmograph wave amplitude (PPGA), skin conductance level, number of skin conductance fluctuations, and their time derivatives. The NoL index estimates the nociceptive/antinociceptive state from these component measures using random forest regression. In our department, a combination of TCI propofol (Schnider model) and remifentanil (Minto model) is used to for most of the anaesthetic procedures, including cardiac anaesthesia. Remifentanil is titrated to prevent an increase in blood pressure and hearth rhythm at noxious stimuli, such as surgical incision, and adapted following hemodynamic trend during surgery. The hypothesis of this study is to develop a calibration test using the NOL index variation to define the individual most appropriate NAN balance using remifentanil TCI before the start of surgery and before a very strong noxious surgical stimulus such as surgical incision in non-cardiac and cardiac surgery. Before the start of surgery, the investigators want to titrate in each patient the remifentanil Ce required to abolish the NOL index response to a calibrated noxious tetanic stimulus (Tetanus 60 mamp, 100 Hz, 30 seconds). Thus this individual remifentanil Ce will be the remifentanil level programmed before surgical incision. NOL and hemodynamic responses will be recorded during the entire duration of surgery. Study protocol amendment: validation of the calibration study: Data from the calibration phase will be used to derive a formula to predict individualised anti-nociception for incision.

NCT ID: NCT03323619 Recruiting - Anesthesia Clinical Trials

Impact of Anesthesia Technique on Post-operative Delirium After Transcatheter Aortic Valve Implantation

DELIRIUMTAVI
Start date: November 2, 2017
Phase:
Study type: Observational

Aortic stenosis is a frequent valvulopathy in Europe and North America. It occurs mainly over 65 years (2-7% of the population over 65 years). Treatment of symptomatic stenosis is an indication of aortic valve replacement. For patients with high surgical risk (EuroSCORE II> 6), TAVI (Transcatheter Aortic Valve Implantation) is recommended. This type of procedure concerns elderly patients (75-80 years on average in the literature) therefore the anesthesia technique must be optimal. The postoperative complications are, on the one hand, well-described surgical complications (Cardiogenic shock, bleeding, rhythm disorders, renal insufficiency) and, on the other hand, those related to anesthesia which are less well characterized. There is no consensus on best anesthesia technique for TAVI procedure managment. Between teams practices are different. It may consist of general anesthesia (GA) or local anesthesia with sedation (LASed). Elderly anesthesia has specific complications, including acute cerebral disturbances (delirium) usually occurring within 24 to 48 hours postoperatively and up to 7 days. It is recommended to screen delirium for patients admitted in intensive care using the CAM-ICU scale. The aim of the study is to observe the impact of the anesthesia technique (GA versus LASed) on delirium in post-operative aortic valve replacement with TAVI procedure